JP2006521110A - 肺癌の検出およびモニタリング - Google Patents

肺癌の検出およびモニタリング Download PDF

Info

Publication number
JP2006521110A
JP2006521110A JP2006507083A JP2006507083A JP2006521110A JP 2006521110 A JP2006521110 A JP 2006521110A JP 2006507083 A JP2006507083 A JP 2006507083A JP 2006507083 A JP2006507083 A JP 2006507083A JP 2006521110 A JP2006521110 A JP 2006521110A
Authority
JP
Japan
Prior art keywords
seq
polynucleotide
sequence
patient
lung cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006507083A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006521110A5 (enExample
Inventor
バーバラ ケー． ツェーエントナー−ウィルキンソン，
ドーン シー． ジェイ． ヘーズ，
レイモンド エル． ホートン，
Original Assignee
コリクサ コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コリクサ コーポレイション filed Critical コリクサ コーポレイション
Publication of JP2006521110A publication Critical patent/JP2006521110A/ja
Publication of JP2006521110A5 publication Critical patent/JP2006521110A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2006507083A 2003-03-24 2004-03-10 肺癌の検出およびモニタリング Pending JP2006521110A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45726103P 2003-03-24 2003-03-24
US50299503P 2003-09-15 2003-09-15
PCT/US2004/007451 WO2004084804A2 (en) 2003-03-24 2004-03-10 Detection and monitoring of lung cancer

Publications (2)

Publication Number Publication Date
JP2006521110A true JP2006521110A (ja) 2006-09-21
JP2006521110A5 JP2006521110A5 (enExample) 2007-04-19

Family

ID=33101281

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507083A Pending JP2006521110A (ja) 2003-03-24 2004-03-10 肺癌の検出およびモニタリング

Country Status (6)

Country Link
US (1) US20070042368A1 (enExample)
EP (1) EP1606303A4 (enExample)
JP (1) JP2006521110A (enExample)
AU (1) AU2004224448A1 (enExample)
CA (1) CA2520512A1 (enExample)
WO (1) WO2004084804A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004077021A2 (en) * 2003-02-27 2004-09-10 Lesko Stephen A Standardized evaluation of therapeutic efficacy based on cellular biomarkers
US8921102B2 (en) * 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
EP2029779A4 (en) 2006-06-14 2010-01-20 Living Microsystems Inc HIGHLY PARALLEL SNP GENOTYPING UTILIZATION FOR FETAL DIAGNOSIS
HUE031848T2 (en) 2008-09-20 2017-08-28 Univ Leland Stanford Junior Non-invasive diagnosis of fetal aneuploidy by sequencing
WO2024026284A2 (en) * 2022-07-25 2024-02-01 Interius Biotherapeutics, Inc. Mutated polypeptides, compositions comprising the same, and uses thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002623A2 (en) * 2000-06-29 2002-01-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2002004514A2 (en) * 2000-07-11 2002-01-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20020052329A1 (en) * 1998-03-18 2002-05-02 Tongtong Wang Compositions and methods for the therapy and diagnosis of lung cancer
WO2002086443A2 (en) * 2001-04-18 2002-10-31 Protein Design Labs, Inc Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US660833A (en) * 1900-05-22 1900-10-30 Harry W Bell Partition.
US5795723A (en) * 1994-05-06 1998-08-18 Fred Hutchinson Cancer Research Center Expression of neurogenic bHLH genes in primitive neuroectodermal tumors
US6518256B1 (en) * 1998-03-18 2003-02-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6426072B1 (en) * 2000-08-02 2002-07-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6706262B1 (en) * 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6482597B1 (en) * 1999-12-17 2002-11-19 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6210883B1 (en) * 1998-03-18 2001-04-03 Corixa Corporation Compounds and methods for diagnosis of lung cancer
US6821518B1 (en) * 1998-03-18 2004-11-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6087168A (en) * 1999-01-20 2000-07-11 Cedars Sinai Medical Center Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells
US20030125245A1 (en) * 1999-06-30 2003-07-03 Tongtong Wang Compositions and methods for therapy and diagnosis of lung cancer
US6686447B1 (en) * 1999-06-30 2004-02-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6667154B1 (en) * 1999-06-30 2003-12-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6509448B2 (en) * 1999-06-30 2003-01-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20020172952A1 (en) * 1999-06-30 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6504010B1 (en) * 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030103994A1 (en) * 2001-06-28 2003-06-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020052329A1 (en) * 1998-03-18 2002-05-02 Tongtong Wang Compositions and methods for the therapy and diagnosis of lung cancer
WO2002002623A2 (en) * 2000-06-29 2002-01-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2002004514A2 (en) * 2000-07-11 2002-01-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2002086443A2 (en) * 2001-04-18 2002-10-31 Protein Design Labs, Inc Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer

Also Published As

Publication number Publication date
CA2520512A1 (en) 2004-10-07
EP1606303A4 (en) 2007-11-21
WO2004084804A2 (en) 2004-10-07
EP1606303A2 (en) 2005-12-21
US20070042368A1 (en) 2007-02-22
AU2004224448A1 (en) 2004-10-07
WO2004084804A3 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
EP1272668B1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
CN109825586B (zh) 用于肺癌检测的DNA甲基化qPCR试剂盒及使用方法
JP2012005500A (ja) 食道癌、結腸癌、頭頸部癌、およびメラノーマにおけるマーカーの同定
KR20190026769A (ko) 유전자 발현 프로파일을 사용하여 폐암을 진단하기 위한 조성물 및 방법
CN109504780B (zh) 用于肺癌检测的DNA甲基化qPCR试剂盒及使用方法
JP2006521110A (ja) 肺癌の検出およびモニタリング
KR102555330B1 (ko) SARS-CoV-2 진단용 조성물, 키트 및 이를 이용한 SARS-CoV-2의 진단방법
JP7084034B2 (ja) 神経芽腫の微小残存病変を評価するために用いられる試薬、およびそれを用いた生体試料の分析方法
US20140072971A1 (en) Prame detection assays
CN118308502A (zh) 检测结核分枝杆菌耐药基因的引物组、试剂盒及方法
KR101174369B1 (ko) 유방암 진단용 바이오마커 및 유방암 진단제
JP2004105013A (ja) 肝細胞癌検出法
JPH08510649A (ja) Ｂｃ２００ｒｎａ、それに対するプローブ及びその使用
WO2019186404A1 (en) Methylation-based biomarkers in breast cancer screening, diagnosis, or prognosis
CN117660633A (zh) 标志物在诊断乳腺癌或预测乳腺癌风险中的用途
CN114369661B (zh) 用于乳腺癌筛查的标志物、探针组合物及其应用
JP2011152153A (ja) ガンのリンパ節転移またはそのリスクを判定する方法及びそのための迅速判定キット
US20060292600A1 (en) Methods, compositions and kits for the detection and monitoring of lung cancer
JP2007006792A (ja) 肺腺癌の胸膜浸潤を判別するための遺伝子セット
JP2006510870A (ja) 癌腫の分子診断および予後
US20050255481A1 (en) Progesterone receptor transcript sequences
TW202413655A (zh) 標誌物在診斷乳腺癌或預測乳腺癌風險中的用途
HK40081979A (en) Composition for diagnosing sars-cov-2, kit, and method for diagnosing sars-cov-2 by using same
CN117821621A (zh) 一种马氏巨球菌的分子标记及其应用
BRPI1006640A2 (pt) métodos e reagentes para a detecção precoce de melanoma

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070301

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070301

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20080403

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20081203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100413

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100914